In genetic modeling such mutations have been shown to de-regulate methylation of both tumor suppressor (Rasmussen et al., 2015) and differentiation-specific enhancers (Yang et al., 2016), and in the case of DNMT3A to control the lineage identity of the resulting leukemia (Yang et al., 2016). Here, DNMT3A is linked to leukemia.